{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:10:55Z","timestamp":1788909055318,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neurot.2025.e00620","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T15:06:12Z","timestamp":1750518372000},"page":"e00620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of sex on multiple sclerosis therapy"],"prefix":"10.1016","volume":"22","author":[{"given":"Patricia K.","family":"Coyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.neurot.2025.e00620_bib1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.0000000000007915","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data","volume":"93","author":"Wallin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00620_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115737","article-title":"Gender-based research underscores sex differences in biological processes, clinical disorders and pharmacological interventions","volume":"215","author":"Bernstein","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00620_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2827090","article-title":"Sex and gender differences in central nervous system-related disorders","volume":"2016","author":"Zagni","year":"2016","journal-title":"Neurosci J"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00620_bib4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00620_bib5","first-page":"339","article-title":"Coronavirus COV-19\/SARS-CoV-2 affects women less than men: clinical response to viral infection","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.neurot.2025.e00620_bib6","series-title":"An overview of sex hormones","author":"Aliouche","year":"2022"},{"key":"10.1016\/j.neurot.2025.e00620_bib7","article-title":"Role of estrogen receptors in health and disease","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.neurot.2025.e00620_bib8","series-title":"StatPearls [internet]. Treasure island (FL)","article-title":"Physiology, progesterone","author":"Cable","year":"2023"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00620_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-023-01326-7","article-title":"Hormonal therapies in multiple sclerosis: a review of clinical data","volume":"24","author":"Hsu","year":"2024","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00620_bib10","doi-asserted-by":"crossref","first-page":"e1954","DOI":"10.1212\/WNL.0000000000005612","article-title":"Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women","volume":"90","author":"Koch-Henriksen","year":"2018","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00620_bib11","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurot.2025.e00620_bib12","first-page":"jnnp-2022","article-title":"Shift of multiple sclerosis onset towards older age","author":"Prosperini","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7969","key":"10.1016\/j.neurot.2025.e00620_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41586-023-06250-x","article-title":"Locus for severity implicates CNS resilience in progression of multiple sclerosis","volume":"619","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00620_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105011","article-title":"Age-related differences in the severity of sexua dysfunction symptoms and psychological distress in individuals with multiple sclerosis","volume":"79","author":"Romano","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00620_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3109\/09638288.2013.825332","article-title":"Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction","volume":"36","author":"Vitkova","year":"2014","journal-title":"Disabil Rehabil"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00620_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1474-4422(22)00426-4","article-title":"Family planning considerations in people with multiple sclerosis","volume":"22","author":"Krysko","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurot.2025.e00620_bib17","first-page":"24","article-title":"Practical considerations for family planning in multiple sclerosis","author":"Moehlman","year":"2024","journal-title":"Pract Neurol"},{"key":"10.1016\/j.neurot.2025.e00620_bib18","doi-asserted-by":"crossref","first-page":"620772","DOI":"10.3389\/fneur.2021.620772","article-title":"Family planning decision making in people with multiple sclerosis","volume":"12","author":"Bonavita","year":"2021","journal-title":"Front Neurol"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00620_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","article-title":"Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00620_bib20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/1352458517701314","article-title":"Contraception for women with multiple sclerosis: guidance for healthcare providers","volume":"23","author":"Houtchens","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurot.2025.e00620_bib21","first-page":"1","article-title":"Contraception and birth control methods","year":"2024","journal-title":"Contraception"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00620_bib22","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2021.21392","article-title":"Contraception selection, effectiveness, and adverse effects: a review","volume":"326","author":"Teal","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00620_bib23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.neurol.2021.11.009","article-title":"Genetics and familial distribution of multiple sclerosis: a review","volume":"178","author":"Balcerac","year":"2022","journal-title":"Rev Neurol (Paris)"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00620_bib24","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1073\/pnas.1932604100","article-title":"Twin concordance and sibling recurrence rates in multiple sclerosis","volume":"100","author":"Willer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00620_bib25","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210170","article-title":"Peripartum mental illness in mothers with multiple sclerosis and other chronic diseases in Ontario, Canada","volume":"104","author":"Marrie","year":"2025","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00620_bib26","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213366","article-title":"Peripartum mental illness in mothers with multiple sclerosis merits neurologists' attention","volume":"104","author":"Ross","year":"2025","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00620_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imm.13004","article-title":"Impact of sex hormones on immune function and multiple sclerosis development","volume":"156","author":"Ysrraelit","year":"2019","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00620_bib28","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200253","article-title":"Practical considerations for managing pregnancy in patients with multiple sclerosis: dispelling the myths","volume":"14","author":"Graham","year":"2024","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00620_bib29","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00330-023-10151-y","article-title":"Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group","volume":"34","author":"Rovira","year":"2024","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00620_bib30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00620_bib31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/bdra.23248","article-title":"Corticosteroid use and risk of orofacial clefts","volume":"100","author":"Skuladottir","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.neurot.2025.e00620_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.reprotox.2017.02.006","article-title":"The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis","volume":"69","author":"Xiao","year":"2017","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.neurot.2025.e00620_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1090133","article-title":"The protective role of breastfeeding in multiple sclerosis: latest evidence and practical considerations","volume":"13","author":"Collorone","year":"2023","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00620_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jamaneurol.2019.4173","article-title":"Association between breastfeeding and postpartum multiple sclerosis relapses: a systematic review and meta-analysis","volume":"77","author":"Krysko","year":"2020","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00620_bib35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/jnnp-2022-330533","article-title":"Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis","volume":"94","author":"Schubert","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00620_bib36","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/ph16050770","article-title":"Monoclonal antibodies in pregnancy and breastfeeding in patients with multiple sclerosis: a review and an updated clinical guide","volume":"16","author":"Gklinos","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00620_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurot.2025.e00620_bib38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/brain\/awh152","article-title":"Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse","volume":"Jun;127(Pt 6):","author":"Vukusic","year":"2004","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00620_bib39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/1352458513507816","article-title":"Predictors and dynamics of postpartum relapses in women with multiple sclerosis","volume":"20","author":"Hughes","year":"2014","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00620_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40120-022-00421-0","article-title":"Multiple sclerosis in pregnancy: a commentary on disease modification and symptomatic drug therapies","volume":"12","author":"Iyer","year":"2023","journal-title":"Neurol Ther"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00620_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11940-021-00666-4","article-title":"Treatment of women with multiple sclerosis planning pregnancy","volume":"23","author":"Krysko","year":"2021","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.neurot.2025.e00620_bib42","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00620_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44750","article-title":"Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy","volume":"5","author":"Hellwig","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.neurot.2025.e00620_bib44","first-page":"104038","volume":"66","author":"Valero-L\u00f3pez","year":"2022","journal-title":"Treatment with natalizumab during pregnancy in multiple sclerosis: the experience of implementing a clinical practice protocol (NAP-30). Mult Scler Relat Disord"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00620_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/jnnp-2023-332804","article-title":"Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy","volume":"95","author":"Thiel","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00620_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/pn-2022-003426","article-title":"Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines","volume":"23","author":"Dobson","year":"2023","journal-title":"Pract Neurol"},{"key":"10.1016\/j.neurot.2025.e00620_bib47","unstructured":"HIGHLIGHTS of PRESCRIBING INFORMATION. https:\/\/www.tgtherapeutics.com\/label-prescribing-info\/uspi-briumvi.pdf."},{"key":"10.1016\/j.neurot.2025.e00620_bib48","doi-asserted-by":"crossref","first-page":"104716","DOI":"10.1016\/j.msard.2023.104716","article-title":"Cryopreservation of ovarian tissue as fertility preservation in young women with multiple sclerosis before stem cell transplantation","volume":"74","author":"Colmorn","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurot.2025.e00620_bib49","doi-asserted-by":"crossref","first-page":"105893","DOI":"10.1016\/j.msard.2024.105893","article-title":"Multiple sclerosis: pregnancy, fertility, and assisted reproductive technology-a review","volume":"92","author":"Oreja-Guevara","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00620_bib50","doi-asserted-by":"crossref","first-page":"103980","DOI":"10.1016\/j.rbmo.2024.103980","article-title":"Is infertility more common among patients with multiple sclerosis? Implications for utilization of assisted reproductive techniques","volume":"49","author":"Skvirsky","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.neurot.2025.e00620_bib51","first-page":"1","article-title":"About ART","year":"2024","journal-title":"Assist Reprod Technol"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00620_bib52","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1177\/1352458519865118","article-title":"Effect of assisted reproductive technology on multiple sclerosis relapses: case series and meta-analysis","volume":"26","author":"Bove","year":"2020","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00620_bib53","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200106","article-title":"Inflammatory activity after diverse fertility treatments: a multicenter analysis in the modern multiple sclerosis treatment era","volume":"10","author":"Graham","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00620_bib54","doi-asserted-by":"crossref","first-page":"e1916","DOI":"10.1212\/WNL.0000000000201027","article-title":"Assessing the risk of relapse requiring corticosteroids after in vitro fertilization in women with multiple sclerosis","volume":"99","author":"Mainguy","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00620_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clim.2013.03.014","article-title":"Role of puberty in multiple sclerosis risk and course","volume":"149","author":"Chitnis","year":"2013","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00620_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11910-021-01115-0","article-title":"Effects of the menstrual cycle on neurological disorders","volume":"21","author":"Roeder","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00620_bib57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1468-1331.2008.02431.x","article-title":"Age of puberty and the risk of multiple sclerosis: a population based study","volume":"16","author":"Ramagopalan","year":"2009","journal-title":"Eur J Neurol"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00620_bib58","doi-asserted-by":"crossref","first-page":"e1803","DOI":"10.1212\/WNL.0000000000007325","article-title":"Effect of age at puberty on risk of multiple sclerosis: a mendelian randomization study","volume":"92","author":"Harroud","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00620_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105499","article-title":"Effect of hormonal changes on the neurological status in the menstrual cycle of patient with multiple sclerosis","volume":"186","author":"Guven Yorgun","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00620_bib60","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1212\/WNL.53.3.622","article-title":"MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns","volume":"53","author":"Pozzilli","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00620_bib61","doi-asserted-by":"crossref","first-page":"104864","DOI":"10.1016\/j.msard.2023.104864","article-title":"Influence of menstrual cycle and hormonal contraceptive use on MS symptom fluctuations: a pilot study","volume":"77","author":"Taylor","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurot.2025.e00620_bib62","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210228","article-title":"Association of menopause with functional outcomes and disease biomarkers in women with multiple sclerosis","volume":"104","author":"Silverman","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00620_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16566","article-title":"The influence of menopause on multiple sclerosis","volume":"32","author":"Simonsen","year":"2025","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurot.2025.e00620_bib64","doi-asserted-by":"crossref","first-page":"105517","DOI":"10.1016\/j.msard.2024.105517","article-title":"The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis","volume":"85","author":"Juutinen","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00620_bib65","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/13524585241254989","article-title":"All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated","volume":"30","author":"Petheram","year":"2024","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00620_bib66","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/ene.15299","article-title":"Hormone therapy and disease activity in Danish women with multiple sclerosis: a population-based cohort study","volume":"29","author":"Kopp","year":"2022","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00620_bib67","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jnnp-2022-328994","article-title":"Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis","volume":"93","author":"Magyari","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurot.2025.e00620_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.msard.2017.01.001","article-title":"Sex differences in outcomes of disease-modifying treatments for multiple sclerosis: a systematic review","volume":"12","author":"Li","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurot.2025.e00620_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.yfrne.2018.07.001","article-title":"A case for gender-based approach to multiple sclerosis therapeutics","volume":"50","author":"Houtchens","year":"2018","journal-title":"Front Neuroendocrinol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00620_bib70","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1007\/s00415-024-12270-y","article-title":"Sex impacts treatment decisions in multiple sclerosis","volume":"271","author":"Hegen","year":"2024","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00620_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(15)00322-1","article-title":"Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Voskuhl","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurot.2025.e00620_bib72","first-page":"jnnp-2024","article-title":"Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis","volume":"13","author":"Giordano","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00620_bib73","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/jpm11101006","article-title":"What can we learn from sex differences in MS?","volume":"11","author":"Coyle","year":"2021","journal-title":"J Pers Med"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00620_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122686","article-title":"Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS","volume":"10","author":"Ribbons","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00620_bib75","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00415-024-12250-2","article-title":"Male sexual and reproductive health in multiple sclerosis: a scoping review","volume":"271","author":"Toljan","year":"2024","journal-title":"J Neurol"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00620_bib76","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.3390\/jcm10225401","article-title":"Effect of multiple sclerosis and its treatments on male fertility: cues for future research","volume":"10","author":"Massarotti","year":"2021","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00620_bib77","first-page":"377","article-title":"Family planning in men and women with multiple sclerosis. Analysis of the Andalusian Registry","volume":"76","author":"Vidal-de Francisco","year":"2023","journal-title":"Rev Neurol (2018-2022)"},{"key":"10.1016\/j.neurot.2025.e00620_bib78","doi-asserted-by":"crossref","first-page":"103347","DOI":"10.1016\/j.msard.2021.103347","article-title":"Teriflunomide levels in women whose male sexual partner is on teriflunomide for relapsing multiple sclerosis","volume":"57","author":"Guarnaccia","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00620_bib79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1352458517737395","article-title":"The role of testosterone in MS risk and course","volume":"24","author":"Chitnis","year":"2018","journal-title":"Mult Scler"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T13:05:35Z","timestamp":1755090335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925000984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1878747925000984"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00620","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of sex on multiple sclerosis therapy","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00620"}}